Skip to content

To study the effect of Dadimadi Churna in the management of Peenasa

A single arm clinical study to evaluate the efficacy of Dadimadi Churna in the management of Peenasa (Chronic Rhinitis) in children

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048840
Enrollment
36
Registered
2023-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Dr. Saurabh Mhaske
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients having at least 2 â?? 3 symptoms of Peenasa are as follows- Nasastrava,Frequency of Kshavathu ,Nasavarodha, Nasakandu and Shirashoola.The patients of age from 3 year to 12 years. The patients who separents are ready to participate in the clinical trial by giving informed written consent.

Exclusion criteria

Exclusion criteria: Patients and his/her parents/guardian not willing for trial.Patients having life threatening illness and who is bedridden.Patient who need surgical and other intervention.Patients presenting with symptoms of Dushta Peenasa/ Pratishyaya and Raktaga.Patients suffering with other Nasal diseases like Nasal Polyps, Nasal Septum Patients associated with Nasal Malignancy

Design outcomes

Primary

MeasureTime frame
Reduction in the symptoms of PeenasaTimepoint: 7 day study , 0th,3rd ,7th day

Secondary

MeasureTime frame
To observe the adverse effect of Dadimadi ChurnaTimepoint: 7 day study , 0th,3rd ,7th day

Countries

India

Contacts

Public ContactDr Ravindra Rajpal

Dr.D.Y.Patil College of Ayurved and Research Centre,Sant Tukaram Nagar,Pimpri,Pune 411018

ravirajpal24@gmail.com9922037201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026